Centessa Pharmaceuticals logo

Centessa Pharmaceuticals Funding & Investors

Centessa Pharmaceuticals is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process. The company applies an asset-centric R&D model at scale to advance a portfolio of highly validated programs led by industry-leading teams. Each program is developed by a Centessa Subsidiary and supported by a centralized infrastructure and the Centessa management team.

centessa.com

Total Amount Raised: $550,000,000

Centessa Pharmaceuticals Funding Rounds

  • Post Ipo Debt

    $300,000,000

    Post Ipo Debt Investors

    Oberland Capital
  • Series A

    $250,000,000

    Series A Investors

    General Atlantic
    Henderson Global Investors
    Vida Ventures
    EcoR1 Capital
    LifeSci Venture Partners
    Samsara BioCapital
    T. Rowe Price
    Wellington Management
    Boxer Capital
    Cormorant Asset Management
    Biotechnology Value Fund
    Venrock Healthcare Capital Partners
    Logos Capital
    Franklin Resources
    IP Group
Funding info provided by Diffbot.